Moderna, Inc. Common Stock

MRNANASDAQUSD
63.96 USD
2.16 (3.50%)AT CLOSE (11:59 AM EDT)
63.96
0.01 (0.01%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
63.96
0.01 (0.01%)
🔴Market: CLOSED

Moderna, Inc. Common Stock (MRNA) is currently trading at $63.96. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, MRNA is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 18, 2026.

Open?$63.96
High?$67.74
Low?$60.73
Prev. Close?$61.80
Volume?24.1M
Avg. Volume?8.1M
VWAP?$63.56
Rel. Volume?2.97x
Bid / Ask
Bid?$63.90 × 900
Ask?$64.01 × 800
Spread?$0.11
Midpoint?$63.96
Valuation & Ratios
Market Cap?25.4B
Shares Out?396.8M
Float?361.1M
Float %?91.0%
P/E Ratio?N/A
P/B Ratio?3.43
EPS?-$8.05
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Employees
4.7K
Market Cap
25.4B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2018-12-07
Address
325 BINNEY STREET
CAMBRIDGE, MA 02142
Phone: (617) 714-6500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
92
Momentum?
35
Short Sent.?
19
Piotroski F-Score?1/9Weak
Altman Z-Score?4.01Safe
Confidence?58%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?16.01%High
Short Interest?57.8M
Days to Cover?12.3
Free Float361.1M
Avg Daily Volume4.7M
Settlement Date2026-05-29
Financial Health
Current Ratio?2.41Strong
Quick Ratio?2.35Strong
Cash Ratio?0.80Adequate
Debt/Equity?0.08Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
58/100
P/E?
N/A
P/B?
Peers
70
S&P
50
3.43FAIR
P/S?
Peers
55
S&P
6
11.41HIGH
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
97
-7.6CHEAP
EV/Sales?
Peers
55
S&P
9
10.82HIGH
Returns & Efficiency
ROE?
Peers
11
S&P
3
-43.1%WEAK
ROA?
Peers
13
S&P
3
-27.8%WEAK
Cash Flow & Enterprise
FCF?$-1603000000
Enterprise Value?$24.1B
Fundamentals ratios updated end of day